Fidelity Investments’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71K Sell
901
-2
-0.2% -$6 ﹤0.01% 5114
2026
Q1
$2.19K Hold
903
﹤0.01% 5023
2025
Q4
$3.94K Sell
903
-314
-26% -$1.7K ﹤0.01% 4929
2025
Q3
$5.11K Buy
1,217
+314
+35% +$1.11K ﹤0.01% 4779
2025
Q2
$2.59K Sell
903
-397
-31% -$1.05K ﹤0.01% 4824
2025
Q1
$3.51K Sell
1,300
-171
-12% -$642 ﹤0.01% 4788
2024
Q4
$3.47K Buy
1,471
+217
+17% +$577 ﹤0.01% 4727
2024
Q3
$2.97K Sell
1,254
-2,497
-67% -$5.5K ﹤0.01% 4726
2024
Q2
$7.31K Buy
3,751
+3,349
+833% +$11.4K ﹤0.01% 4432
2024
Q1
$2.58K Buy
402
+247
+159% +$2.24K ﹤0.01% 4649
2023
Q4
$2.17K Sell
155
-223
-59% -$3.52K ﹤0.01% 4627
2023
Q3
$9.26K Buy
+378
New +$9.58K ﹤0.01% 4136

Other funds holding GNLX

Fidelity Investments's GNLX Position: Q2 2026 in Review

Fidelity Investments reduced its Genelux (GNLX) stake by 0.22% in Q2 2026, selling an estimated $6 and leaving 901 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #5114.

Fidelity Investments first reported a position in GNLX in Q3 2023 and has held it in 12 quarters since. The position peaked at $9.26K in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Fidelity Investments held 901 shares of Genelux worth $2.71K as of Q2 2026.
  • Fidelity Investments sold 2 Genelux shares in Q2 2026, an estimated $6.
  • Genelux made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5114 holding.
  • Fidelity Investments first reported a position in Genelux in Q3 2023 and has held it in 12 quarters since.
  • Fidelity Investments's Genelux position peaked at $9.26K in Q3 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.